Brief: Hillstream Biopharma Regains Compliance With Nasdaq Listing Minimum Bid Price Rule
15/02/2023 13:17
Feb 15 (Reuters) - Hillstream BioPharma Inc HILS.O :
* HILLSTREAM BIOPHARMA REGAINS COMPLIANCE WITH NASDAQ
LISTING
MINIMUM BID PRICE RULE
Source text for Eikon: ID:nGNX3CkdS2
Further company coverage: HILS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Canton Strategic Holdings
See all newsBrief: Canton Strategic Holdings, Inc. Expected To Be Included In Russell 3000® And Russell 2000®
Brief: Canton Strategic Authorizes Share Repurchase Program For Up To $50 Million In Common Stock
Canton Strategic Holdings Q1 net loss widens on higher expenses
Brief: Canton Strategic Holdings Reports Full Year 2025 Financial And Operational Results
Brief: Canton Strategic Holdings Inc - Enters Amended Sales Agreement With Clear Street And Virtu Americas - SEC Filing